{
    "medicine_id": "8bf11c7acf44d3088be8ee1e4011320c3d8fcf12",
    "platform_id": "DB00724",
    "metadata": {
        "name": "Aldara 50 mg 1000mg Cream",
        "composition": "50 mg 1000mg Imiquimod",
        "clinical_particulars": {
            "therapeutic_indications": "For the topical treatment of clinically typical nonhyperkeratotic nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults Also indicated for the treatment of external genital and perianal warts condyloma acuminata in individuals 12 years old and above",
            "contraindications": {
                "disease": "Symptoms of overdose include flu like symptoms such as fever fatigue headache nausea diarrhoea and muscle pain",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Imiquimod is an immune response modifier that acts as a toll like receptor 7 agonist Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas Imiquimod does not cure warts and new warts may appear during treatment Imiquimod does not fight the viruses that cause warts directly however it does help to relieve and control wart production It is not used on warts inside the vagina penis or rectum Imiquimod is also used to treat a skin condition of the face and scalp called actinic keratoses Imiquimod can also be used to treat certain types of skin cancer called superficial basal cell carcinoma Imiquimod is particularly useful on areas where surgery or other treatments may be difficult complicated or otherwise undesirable especially the face and lower legs",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Imiquimod"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Imiquimod"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Imiquimod can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Imiquimod"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Imiquimod can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Imiquimod can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Imiquimod"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Imiquimod"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Imiquimod is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Imiquimod can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Imiquimod can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}